Details
Category: Volume 06 Issue 11 November 2018
Hits: 1199

Title: Correlating Uric Acid levels with Echocardiographic findings in Pulmonary Hypertension

Authors: Dr Vishvesh Patel, Dr Varun Shetty, Dr Santawana Chandrakar

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i11.47

Abstract

Introduction: Pulmonary hypertension (PH) is characterized by elevated pulmonary arterial pressure and secondary right ventricular failure and can be a diagnostic challenge. This study aimed at assessing how uric acid levels correlate with echocardiographic findings of PH.

Methodology: We performed a case-control study in the Department of Medicine, DY Patil School of Medicine and Hospital, Navi Mumbai from July 2017 till July 2018.  All consecutive patients who were diagnosed with PH at our centre during the study period and age/gender matched controls were enrolled in the study. Transthoracic echocardiography and relevant haematological investigations were ordered.

Results: Demographic variables of both the study groups were similar at the baseline. Serum uric acid levels were significantly higher among cases (9.17 ± 1.37 mg/dl) as compared to controls (6.62 ± 1.83 mg/dl, p value <0.05). Echocardiography revealed that the systolic and diastolic ejection fractions were not significantly different among cases or controls. Systolic pulmonary artery pressure was significantly higher among cases as compared to controls (27.2 ± 2.2 vs 18.5 ± 2.7 mm Hg, p value <0.05). Similarly, diastolic and mean pulmonary artery pressures were also higher among cases as compared to controls. Furthermore, we found the uric acid levels to be significantly positively correlated with systolic pulmonary artery pressure (r = 0.75, p value <0.001), and inversely correlated with left ventricular ejection fraction (r = -0.44, p value <0.01) and right ventricular ejection fraction (r= -0.62, p value < 0.01).

Conclusions: There is a strong and significant positive correlation between systolic pulmonary artery pressure and uric acid levels and inverse correlation with ejection fractions.

Keywords: uric acid; pulmonary hypertension; pulmonary arterial pressure; hyperuricemia

References

  1. Leyva F, Anker S, Swan JW, et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J 1997; 18: 858-65.
  2. Hayabuchi Y, Matsuoka S, Akita H, Kuroda Y. Hyperuricaemia in cyanotic congenital heart disease. Eur J Pediatr 1993; 152: 873-6.
  3. Elsayed NM, Nakashima JM, Postlethwait EM. Measurement of uric acid as a marker of oxygen tension in the lung. Arch BiochemBiophys 1993; 302: 228-32.
  4. Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009;30:2493–2537
  5. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in coll*aboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am CollCardiol. 2009;53:1573–1619.
  6. Mukerjee D, St George D, Knight C, et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. RheumatolOxf Engl. 2004;43:461–466.
  7. Ino T, Benson LN, Mikalian H, Freedom RM, Rowel RD (1989) Determination of left ventricular volumes by Simpson’s rule in infants and children with congenital heart disease. Br Heart J 61: 182–185.
  8. Heys JJ, Holyoak N, Calleja AM, Belohlavek M, Chaliki HP. Revisiting the simplified bernoulli equation. The open biomedical engineering journal. 2010;4:123.
  9. Bossone E, Bodini BD, Mazza A, Allegra L. Pulmonary arterial hypertension: the key role of echocardiography. Chest 2005; 127:1836.
  10. Bergamini C, Cicoira M, Rossi A, Vassanelli C. Oxidative stress and hyperuricaemia: Pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure. Eur J Heart Fail 2009; 11: 444–452.
  11. Van Albada ME, Loot FG, Fokkema R, Roofthooft MT, Berger RM. Biological serum markers in the management of pediatric pulmonary arterial hypertension. Pediatr Res 2008; 63: 321–327.
  12. Voelkel MA, Wynne KM, Badesch DB, Groves BM, Voelkel NF. Hyperuricemia in severe pulmonary hypertension. Chest. 2000 Jan 1;117(1):19-24.
  13. Gotsman I, Keren A, Lotan C, Zwas DR. Changes in uric acid levels and allopurinol use in chronic heart failure: association with improved survival. J Card Fail 2012;18:694e701.
  14. Cingolani HE, Plastino JA, Escudero EM, Mangal B, Brown J, Pérez NG. The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study. Journal of cardiac failure. 2006 Sep 1;12(7):491-8.

Corresponding Author

Dr Vishvesh Patel

Dept of General Medicine, DY Patil University, School of Medicine Nerul, Navi Mumbai-400706, India

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.